Remove Drug Development Remove How To Remove Leadership Remove Life Science
article thumbnail

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

It can test thousands of protocol variations and discover the optimal trial design for success, helping research and development (R&D) teams more accurately and rapidly predict clinical trial results and decide whether a trial should proceed, how to optimize cohorts, whether drugs can be repurposed, and other crucial factors.

article thumbnail

Uses of AI in Healthcare – 2024 Health IT Predictions

Healthcare IT Today

The coming year will see exploration of how to apply the technology, but we will not yet see a full integration of generative AI within labeling. Automation in the form of generative artificial intelligence within labeling is highly anticipated, but it will take time to build confidence in the technology.

Health IT 106